More Stories

Informist, Wednesday, Dec. 24, 2025

 

MUMBAI – Apollo Hospitals Enterprise Ltd. Wednesday said the company has received an observation letter with 'no objections' from the National Stock Exchange for the scheme of arrangement among the company, its material subsidiary Apollo Healthco Ltd., Keimed Pvt. Ltd., and the resultant demerged company Apollo Healthtech Ltd. This follows the company receiving the Competition Commission of India's approval for the scheme in September, Apollo Hospitals said in an exchange filing.

 

In June, Apollo Hospitals' board approved the demerger of its omnichannel pharmacy business and the digital healthcare platform business, amalgamation of its subsidiaries Apollo Healthco and Keimed into Apollo Healthtech and the consequent listing of the shares of the latter. No cash consideration will be discharged under this scheme, Apollo Hospitals had said in an earlier exchange filing. Shareholders of Apollo Hospitals will receive 195.2 shares of Apollo Healthtech for every 100 shares held.

 

Listing of the shares of Apollo Healthtech in the stock market will be subject to fulfilment of the exchanges' criteria for listing and other applicable statutory requirements, the NSE said in the observation letter issued to the company. The validity of this observation letter shall be six months from Tuesday, within which the scheme shall be submitted to the National Company Law Tribunal, NSE said. 

 

Apollo Healthco is engaged in the business of wholesale trading of pharmaceutical and other products and operating the Apollo 24/7 digital platform. Keimed is engaged in the business of distributing wholesale pharmaceutical, healthcare and wellness products. Pursuant to the scheme, the resultant company, Apollo Healthtech, will be engaged in the omnichannel pharmacy distribution business and the digital healthcare platform business. Apollo Hospitals will retain 15% stake in the demerged company and will have one nominee director on its board, it said in an earlier filing.

 

For the quarter ended September, Apollo Hospitals reported a consolidated net profit of INR 4.77 billion on a revenue of INR 63.04 billion. At 1108 IST, the stock was up 1.5% at INR 7,180 on the National Stock Exchange.  End

 

IST, or Indian Standard Time, is five-and-a-half hours ahead of GMT

 

Reported by Arya S. Biju

Edited by Tanima Banerjee

 

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

 

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.

 

Informist Media Tel +91 (22) 6985-4000

Send comments to feedback@informistmedia.com

 

© Informist Media Pvt. Ltd. 2025. All rights reserved.